Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mitchell W. Dillon"'
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 4, Pp n/a-n/a (2020)
Abstract Background RASopathies are a group of disorders caused by disruptions to the RAS‒MAPK pathway. Despite being in the same pathway, Neurofibromatosis Type 1 (NF1) and Legius syndrome (LS) typically present with phenotypes distinct from Noona
Externí odkaz:
https://doaj.org/article/9fbe2bc5222e4e9e97bdc5d015997dd1
Autor:
Gidon Akler, Ashley H. Birch, Nicole Schreiber‐Agus, Xiaoqiang Cai, Guiqing Cai, Lisong Shi, Chunli Yu, Anastasia M. Larmore, Geetu Mendiratta‐Vij, Lama Elkhoury, Mitchell W. Dillon, Jun Zhu, Andrew S. Mclellan, Funda E. Suer, Bryn D. Webb, Eric E. Schadt, Ruth Kornreich, Lisa Edelmann
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 2, Pp n/a-n/a (2020)
Abstract Background Next‐generation sequencing (NGS)‐based panels have gained traction as a strategy for reproductive carrier screening. Their value for screening Ashkenazi Jewish (AJ) individuals, who have benefited greatly from population‐wid
Externí odkaz:
https://doaj.org/article/6d3ee0c27468471986227a368547920f
Autor:
Paola Nicoletti, Shahad Rahawi, Richard Wallsten, Stuart A. Scott, Neal Cody, Robert Rigobello, Hetanshi Naik, Aniwaa Owusu Obeng, Mitchell W Dillon
Publikováno v:
Clinical pharmacology and therapeutics. 108(5)
Autor:
Gidon Akler, Ashley H. Birch, Nicole Schreiber‐Agus, Xiaoqiang Cai, Guiqing Cai, Lisong Shi, Chunli Yu, Anastasia M. Larmore, Geetu Mendiratta‐Vij, Lama Elkhoury, Mitchell W. Dillon, Jun Zhu, Andrew S. Mclellan, Funda E. Suer, Bryn D. Webb, Eric E. Schadt, Ruth Kornreich, Lisa Edelmann
The cover image is based on the Original Article Lessons learned from expanded reproductive carrier screening in self‐reported Ashkenazi, Sephardi, and Mizrahi Jewish patients by Gidon Akler et al., https://doi.org/10.1002/mgg3.1053. [Image: see te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e283b3feb4366124461802cc7aae1119
https://europepmc.org/articles/PMC7005609/
https://europepmc.org/articles/PMC7005609/
Autor:
Geetu Mendiratta‐Vij, Xiaoqiang Cai, Lisong Shi, Mitchell W Dillon, Guiqing Cai, Andrew S McLellan, Ashley H. Birch, Funda E. Suer, Anastasia M. Larmore, Lisa Edelmann, Gidon Akler, Eric E. Schadt, Bryn D. Webb, Nicole Schreiber‐Agus, Chunli Yu, Jun Zhu, Lama Elkhoury, Ruth Kornreich
Publikováno v:
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine, Vol 8, Iss 2, Pp n/a-n/a (2020)
Molecular Genetics & Genomic Medicine, Vol 8, Iss 2, Pp n/a-n/a (2020)
Background Next‐generation sequencing (NGS)‐based panels have gained traction as a strategy for reproductive carrier screening. Their value for screening Ashkenazi Jewish (AJ) individuals, who have benefited greatly from population‐wide targete
Autor:
Nicola Whiffin, Steven M. Harrison, Jodie Ingles, K Thomson, Roddy Walsh, Kate M. Orland, Matthew J Thomas, Mitchell W Dillon, Ana Morales, Katherine Spoonamore, Daniela Macaya, Ray E. Hershberger, Zena T. Wolf, Birgit Funke, Lisa M. Vincent, Hugh Watkins, Gabriele Richard, J. Peter van Tintelen, Arjun K. Manrai, James S. Ware, Christopher Semsarian, Colleen Caleshu, Eden Haverfield, Jillian G. Buchan, Melissa A. Kelly, Stuart A. Cook, Jan D. H. Jongbloed, John Garcia
Publikováno v:
Genetics in Medicine, 20(3), 351-359. Nature Publishing Group
Genetics in medicine, 20, 351-359. Lippincott Williams and Wilkins
Genetics in Medicine
Genetics in medicine, 20, 351-359. Lippincott Williams and Wilkins
Genetics in Medicine
Purpose Integrating genomic sequencing in clinical care requires standardization of variant interpretation practices. The Clinical Genome Resource has established expert panels to adapt the American College of Medical Genetics and Genomics/Associatio
Publikováno v:
Clinical Dysmorphology. 26:101-106
Publikováno v:
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine, Vol 8, Iss 4, Pp n/a-n/a (2020)
Molecular Genetics & Genomic Medicine, Vol 8, Iss 4, Pp n/a-n/a (2020)
Background RASopathies are a group of disorders caused by disruptions to the RAS‒MAPK pathway. Despite being in the same pathway, Neurofibromatosis Type 1 (NF1) and Legius syndrome (LS) typically present with phenotypes distinct from Noonan spectru
Publikováno v:
Prenatal Diagnosis. 36:418-423
Objectives Noonan spectrum disorders (NSDs) occur in 1:1000–2500 live births. Currently, there are no guidelines for prenatal molecular genetic testing for NSDs. Recent studies recommend prenatal testing for NSDs when ultrasonography detects two or
Autor:
Karen W. Gripp, Heather Mason-Suares, Jennifer A. Lee, Brandon J. Cushman, Andrew R. Grant, Martin Zenker, Lisa M. Vincent, Bruce D Gelb, Hélène Cavé, Mitchell W Dillon, Katherine A. Rauen
The RASopathies are a complex group of diseases regarding phenotype and genetic etiology. The ClinGen RASopathy Expert Panel assessed published and other publicly available evidence supporting the association of 19 genes with RASopathy conditions. Us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e73bf31fc4e52656ff46e2c969628f2e